[28] Several inhibitors of LAT1 have been developed and were found effective in suppressing tumor growth, cell migration and invasion [29], and increasing the sensitivity of the cancer cells to diverse therapeutic drugs such as gemcitabine, 5-FU [30], and cisplatin. Here, SLC7A5 is linked to cancer.